Hung‐Yuan Chen

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients

Hung‐Yuan Chen, I-Chih Cheng, Yi‐Ju Pan et al. · Kidney International · 2011 · 134 citations

Sleep Disorders, Sleep, Hemodialysis +11

Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis

Mei‐Ju Ko, Yu‐Sen Peng, Hung‐Yuan Chen et al. · Journal of the American Academy of Dermatology · 2014 · 116 citations

Inflammation, Glomerulonephritis, Hemodialysis +11

Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Peritoneal Dialysis: A Pilot Randomized Controlled Trial

Hung‐Yuan Chen, Chih‐Kang Chiang, Hsi‐Hao Wang et al. · American Journal of Kidney Diseases · 2008 · 107 citations

Sleep Disorders, Sleep, Sleep Disorder +9